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The FAD synthetase from the 
human pathogen Streptococcus 
pneumoniae: a bifunctional enzyme 
exhibiting activity-dependent 
redox requirements
María Sebastián1,2, Erandi Lira-Navarrete2,6, Ana Serrano1,2,7, Carlos Marcuello3,8, Adrián 
Velázquez-Campoy1,2,4,5, Anabel Lostao  3,4, Ramón Hurtado-Guerrero2,4, Milagros Medina 
 1,2 & Marta Martínez-Júlvez  1,2
Prokaryotic bifunctional FAD synthetases (FADSs) catalyze the biosynthesis of FMN and FAD, 
whereas in eukaryotes two enzymes are required for the same purpose. FMN and FAD are key 
cofactors to maintain the flavoproteome homeostasis in all type of organisms. Here we shed light 
to the properties of the hitherto unstudied bacterial FADS from the human pathogen Streptococcus 
pneumoniae (SpnFADS). As other members of the family, SpnFADS catalyzes the three typical activities 
of prokaryotic FADSs: riboflavin kinase (RFK), ATP:FMN:adenylyltransferase (FMNAT), and FAD 
pyrophosphorylase (FADpp). However, several SpnFADS biophysical properties differ from those of 
other family members. In particular; i) the RFK activity is not inhibited by the riboflavin (RF) substrate, 
ii) the FMNAT and FADSpp activities require flavin substrates in the reduced state, iii) binding of adenine 
nucleotide ligands is required for the binding of flavinic substrates/products and iv) the monomer is 
the preferred state. Collectively, our results add interesting mechanistic differences among the few 
prokaryotic bifunctional FADSs already characterized, which might reflect the adaptation of the 
enzyme to relatively different environments. In a health point of view, differences among FADS family 
members provide us with a framework to design selective compounds targeting these enzymes for the 
treatment of diverse infectious diseases.
Prokaryotic FAD synthetases (FADSs) are bifunctional and bimodular enzymes that first catalyze the synthesis of 
flavin mononucleotide (FMN) from riboflavin (RF, vitamin B2) through an ATP:riboflavin kinase activity (RFK, 
EC 2.7.1.26) and subsequently the adenylylation of FMN to produce flavin adenine dinucleotide (FAD) using 
an ATP:FMN:adenylyltransferase activity (FMNAT, EC 2.7.7.2)1–3. For some of them, the FMNAT activity has 
also been shown to be reversible, exhibiting therefore a FAD pyrophosphorylase activity (FADpp)4, 5. In mam-
mals and yeasts two independent enzymes catalyze these reactions6–9. Eukaryotic RFKs exhibit structural homol-
ogy with the C-terminal module of prokaryotic bifunctional FADSs10–12. On the contrary eukaryotic FMNATs 
do not exhibit similarity to the prokaryotic N-terminal modules, which belong to the nucleotidyltransferase 
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superfamily13–15. Since FMN and FAD are essential and versatile cofactors in a plethora of vital redox pro-
cesses16–20, and also participate in signal transduction during apoptosis21, embryonic development22, chromatin 
remodeling23, nucleotide synthesis24, tRNA methylation25, protein folding26, and light dependent processes in 
plants as well as in sensory transduction in microorganisms27–31, their biosynthesis is worth to be understood.
Structures of prokaryotic FADSs are available only for Thermotoga maritima (TmFADS, PDB ID: 1MRZ,11, 32), 
Corynebacterium ammoniagenes (CaFADS, PDB ID: 2X0K10) and the human pathogen Streptococcus pneumoniae 
(SpnFADS, PDB ID: 3OP1). Except for the exhaustive biochemical and biophysical characterization of CaFADS1, 
5, 33, the rest of family members have been poorly studied4, 34, 35. SpnFADS shows the typical sequence and struc-
tural features of prokaryotic bifunctional FADSs, and as such it would be predicted to contain RFK, FMNAT 
and FADpp activities (Supplementary Fig. S1; r.m.s.d. of 1.63 Å encompassing 247 residues and 30% sequence 
identity with CaFADS). The N-terminal module (residues 1–186) is an α/β dinucleotide binding domain that by 
homology to other family members is expected to catalyze the FMNAT and FADpp activities10, 11. Likewise, the 
C-terminal module (residues 187–305), predicted to catalyze the RFK activity10, 36, consists of a β barrel formed 
by six antiparallel β-strands and a long terminal α-helix. The different structures together with the significant 
differences at the catalytic centers between the N-terminal modules of bifunctional FADSs and the mammalian 
FMNAT enzymes10, 14 make prokaryotic FADSs attractive exploitable targets for the treatment of human infec-
tious diseases37. In this context, SpnFADS might be considered as a drug target for S. pneumoniae, a pathogen 
almost exclusive for humans, that is the leading cause of invasive bacterial pneumoniae disease in children, in the 
elderly and in immunodepressed patients38–40.
We present here the biochemical and biophysical characterization of SpnFADS, the only FADS from a path-
ogenic prokaryote whose structure is available. Our data indicate that SpnFADS catalyzes the RFK, FMNAT and 
FADpp activities. However, it differs from other family members in two major catalytic aspects: its RFK activity 
does not exhibit inhibition by the RF substrate and the FMNAT activity requires the flavin substrate in its reduced 
state for substrate binding and catalysis. In addition, the prior binding of adenine nucleotides is required for 
the recognition of flavins, and the enzyme exits mainly in the monomeric state during catalysis. These results 
exemplify how the same type of enzymes from different organisms has evolved different strategies to perform the 
same reaction, presumably due to their unique environment. Our data also point to these bacterial enzymes as 
promising pharmacological targets because not only differ between themselves but also from the human enzyme.
Results
SpnFADS is purified free of flavin ligands. Typically, the yield after purification was 3.5 mg of SpnFADS 
per liter of E.coli culture. Enriched SpnFADS fractions along purification did not show notorious absorbance 
at 450 nm, indicating the purified protein does not contain any flavin bound under these conditions. Thus, the 
final absorption spectrum of purified SpnFADS exhibits a single peak at 279 nm (Supplementary Fig. S2) and in 
contrast to CaFADS13, SpnFADS does not co-purify with FAD, suggesting a much lower affinity for the oxidized 
flavinic substrates/products. The far-ultraviolet (UV) circular dichroism (CD) spectrum of SpnFADS exhibits a 
negative band at 208 nm typical of secondary α-helix structure and a slightly less intense negative band around 
222 nm (Supplementary Fig. S2). Analysis of the far-UV CD spectrum using the method of Raussens41 predicted 
28.3, 19.9, 12.5 and 34.5% of content in α helix, ß strand, turn and random, respectively, in agreement with 
its 3D-structure containing 29% α helix and 28% β strand (Supplementary Fig. S1). Near-UV CD spectrum of 
SpnFADS shows a broad 265–290 nm negative band with minima at 280.5 and 287 nm related with the protein 
tertiary structure organization (Supplementary Fig. S2). Altogether these data indicate that the purified protein 
is correctly folded.
SpnFADS catalyzes the RFK, FMNAT and FADpp activities. A qualitative assay was initially per-
formed to evaluate whether SpnFADS was able to catalyze the RFK, FMNAT and FADpp activities by resolving 
the flavin reaction products by thin layer chromatography (TLC). As shown in Fig. 1A, SpnFADS catalyzes the 
conversion of RF into FMN, both in the absence and in the presence of a reducing agent. However, reducing con-
ditions (2.5 mM of sodium dithionite) are required for the transformation of FMN into FAD (Fig. 1A), as well as 
of FAD into FMN (Fig. 1B).
The reduced state of flavins is critical for the FMNAT activity but not for the RFK one. Prior 
to determining the kinetic parameters for the RFK activity of SpnFADS, we quantitatively evaluated the influ-
ence of the reducing environment (sodium dithionite) as well as of Mg2+ on this reaction. Under saturating 
concentrations of substrates (RF and ATP) rates for RF transformation were independent on the reducing agent 
concentration (Supplementary Fig. S3), indicating that the SpnFADS RFK activity does not depend on its redox 
environment. On the contrary, Mg2+ enhances the RFK activity, being the rate of the process practically constant 
at cation concentrations over 0.4 mM (Supplementary Fig. S3). Thus, herein a concentration of 0.8 mM MgCl2 
was used. Steady-state rates for the RFK activity showed saturation profiles for both substrates (Fig. 1C), contrary 
to CaFADS that has strong inhibition by excess of RF5, 33. Thus, profiles for the RFK activity of SpnFADS were fit 
to the Michaelis-Menten model, allowing determination of kcat, KmRF and KmATP values of 18.7 min−1, 0.9 µM and 
54.0 µM, respectively. These values were only slightly influenced by the presence of the reducing agent (Table 1, 
Fig. 1C).
The FMNAT activity of SpnFADS was determined following the transformation of FMN into FAD. We again 
evaluated first the influence of Mg2+ concentration and of reducing conditions in the FMNAT activity. The pres-
ence of sodium dithionite was a requirement for the transformation of FMN into FAD (Supplementary Fig. S3), 
being the rate of the process constant over 2 mM sodium dithionite. On the contrary, the FMNAT activity was 
very poor in the presence of milder reducing agents as DTT (not shown), suggesting that strong reducing condi-
tions are required to achieve catalysis. Maximal activity was observed in the range of 0.8–1.2 mM of the divalent 
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cation (Supplementary Fig. S3), being the observed rates in its absence up to 5-fold lower. Thus, 0.8 mM MgCl2 
and 3 mM sodium dithionite were selected to further characterize the FMNAT kinetic parameters of SpnFADS. 
Observed rates exhibited Michaelis-Menten saturation profiles (Fig. 1D) with kcat, KmFMN and KmATP values of 
34.9 min−1, 9.8 µM and 31.6 µM, respectively (Table 1). The need of reducing conditions for the FMNAT activity 
suggests that either the isoalloxazine ring of FMN needs to be reduced for the reaction to occur, or the reaction 
depends on a conformational change of the flavin binding site of the FMNAT module of SpnFADS induced by 
the redox environment. To clarify this matter an additional experiment was performed. The FMNAT activity 
of SpnFADS was measured under anaerobic conditions, but in the absence of dithionite, using as substrate the 
photo-reduced FMN. HPLC analysis of the reaction products revealed that SpnFADS is able to transform FMN 
into FAD in the samples containing photo-reduced FMN in contrast with the negative controls where FMN is 
oxidized. Therefore, we conclude that FMN needs to be in its reduced form to get adenylylated by SpnFADS.
SpnFADS does not bind oxidized flavins by itself. Isothermal titration calorimetry (ITC) thermograms 
for the titration of SpnFADS with oxidized RF, FMN or FAD, either in presence or absence of Mg2+, indicated that 
under the assayed aerobic conditions none of these flavins binds to the protein with detectable enthalpic contri-
bution (Supplementary Fig. S4). Therefore, we also titrated SpnFADS with FMN and FAD in a flavin reducing 
buffer and in the presence of 0.8 mM Mg2+. As shown in Fig. 2A, under such conditions binding of the reduced 
Figure 1. The RFK, FMNAT and FADpp activities of SpnFADS. (A) Thin layer chromatography of the products 
of the RFK and FMNAT activities. Reaction mixtures contained around 500 nM SpnFADS, 50 μM RF, 0.2 mM 
ATP, and several concentrations of sodium dithionite. First lane to the left corresponds to a standard solution 
containing RF, FMN and FAD at 50 μM each. (B) Thin layer chromatography of the products of FADpp activity. 
Reaction mixtures contained around 500 nM SpnFADS, 50 μM FAD, 0.2 mM PPi, and several concentrations of 
sodium dithionite. First lane corresponds to the standard solutions and second line to a free FAD sample with 
10 mM MgCl2. (C) Rates for RFK activity as a function of the RF concentration at saturating ATP (412 μM) 
without (●) and with 2.6 mM (■) sodium dithionite. (D) Rates for the FMNAT activity as a function of the 
FMN concentration at saturating ATP (252 μM) and 3 mM sodium dithionite. Unless otherwise stated all 
measurements were carried out at 25 °C in 20 mM PIPES, pH 7.0, with 0.8 mM MgCl2.
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forms of FMN and FAD to the enzyme was detected. Both reduced cofactors bind to a single SpnFADS binding 
site (Fig. 2A and Table 2). KdFMN is in the low micromolar range, and binding of reduced FAD is 15-fold weaker. 
Enthalpic contribution to the binding are very similar for both flavins, but the entropic contributions favor FMN 
binding (Fig. 2C). These results thus indicate that the FMNAT/FADpp sites of SpnFADS only bind the reduced 
states of FMN or FAD.
Thermograms for the titration of SpnFADS with ATP indicated a single binding site for this nucleotide (pre-
sumably at the FMNAT site as in CaFADS), both in the absence and presence of 0.8 mM of Mg2+ (Fig. 2B and 
Table 2), although binding affinities and interaction parameters differ between these two conditions. Thus, 
ATP and ATP:Mg2+ allocate differently into the protein binding site, suggesting that the ion contributes to the 
nucleotide-protein-bound conformation. Titrations at higher Mg2+ concentrations showed two independent ATP 
binding sites, putatively related with each catalytic site, with similar affinities between them, and also similar to 
that of the site found at lower Mg2+ concentrations. However, enthalpic and entropic contributions to the ATP 
binding result highly influenced by Mg2+; in its absence, and at low concentrations, the nucleotide binding is 
enthalpically driven with an opposing entropic contribution, while at high cation concentrations relatively mild 
entropic and enthalpic contributions favor the binding (Fig. 2C). Thermodynamic parameters for the SpnFADS 
titration with ADP also differ depending on Mg2+ concentration. In the absence of the cation, a single high 
affinity binding site is observed, being the binding driven by a favorable enthalpic contribution. At 10 mM of 
Mg2+, a second binding site appears with lower affinity for the nucleotide, being the averaged Kd (Kd,av) at least 
7-times higher. ADP binding in the presence of 10 mM Mg2+ is also enthalpically driven, but in this case the 
enthalpic contribution is much higher, being the entropic term mightily unfavorable. Thus high Mg2+ concen-
trations induce the generation of a second binding site for the adenine nucleotide ligands, both ATP and ADP, 
and influence the way the ligands allocate into the active site, as also supported by the different thermodynamic 
contributions to free energy of the binding.
Thermograms for the titration of mixtures containing SpnFADS plus ADP with oxidized RF or FMN showed 
that the presence of the adenine nucleotide promotes binding of both of these flavins (Fig. 2 and Table 2). Under 
these conditions RF in presence of 10 mM MgCl2, apparently binds at two independent binding sites with mod-
erate affinity, Kd,av 51.3 µM, being the averaged binding enthalpically driven and the entropic contribution highly 
unfavorable. However, in the absence of Mg2+ only one binding site with strong affinity is detected. By contrast 
FMN binds at a single site with stronger affinity than those found for RF, being the binding driven by the enthal-
pic contribution and the binding parameters just modulated by the presence of Mg2+. Finally, binding of FAD 
to SpnFADS in the presence of PPi could not be detected by enthalpic change, similarly to that occurred when 
titrating the PPi-free enzyme with oxidized FAD.
SpnFADS exits mainly as a monomer but other oligomeric states are populated during catal-
ysis. SpnFADS eluted in a main peak with a small shoulder in the gel filtration column used as a last step in 
its purification. The presence of the shoulder might be indicative of freshly purified SpnFADS stabilizing qua-
ternary assemblies, as described for CaFADS1. To check for such possibility we passed through the gel filtration 
RFK activity Reductant kcat (min−1) KmRF (μM)
kcat/KmRF 
(min−1 μM−1) kcat (min−1) KmATP (μM)
kcat/KmATP 
(min−1 μM−1)
SpnFADS
− 18.7 0.9 21.0 19.5a 54.0 0.4
+ 24.1 0.6 41.5 13.4a 34.1 0.4
CaFADSb,c −  < 302  < 13 23.2 68 13.7 4.9
LmFADSId + 0.40 6.9 0.057
HsRFKf + 0.50 36 0.014
BsFADSg + 0.70 55 0.013
SdFADSg + 0.30 40 0.007
EcFADSh + 0.39 2 0.20
FMNAT activity kcat (min−1) KmFMN (µM) kcat/Km
FMN 
(min−1 µM−1) kcat (min
−1) KmATP (µM) kcat/Km
ATP 
(min−1 µM−1)
SpnFADS + 34.9 9.8 3.6 23.2e 31.6 0.7
CaFADSb − 17.0 1.2 14.3 17.0 35.7 0.5
LmFADSId + 4.39 29.2 0.15
LmFADSIId + 0.51 12.9 0.04
EcFADSh + 0.06 4 0.015
Table 1. Steady-state kinetic parameters for the RFK and FMNAT activities of SpnFADS. Parameters obtained 
at 25 °C in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2 and, when indicated 3 mM sodium dithionite as reductant. 
Estimated errors in kcat and Km are within ± 10%. akcat measured at 6 μM of RF. bData from33. Data were obtained 
at 25 °C in 20 mM PIPES, pH 7.0 and 0.8 mM and 10 mM MgCl2, respectively, for the RFK and FMNAT 
activities. cInhibition by substrate prevented the determination of true parameters and these correspond to 
apparent constants, kcat, app, Km, appRF, Km,appATP, kcat,app/Km,appRF and kcat,app/Km,appATP. dData from35. Data obtained 
in 50 mM potassium phosphate, pH 7.5. ekcat measured at 27.7 µM of FMN. fData from42. Data obtained in 
50 mM potassium phosphate, pH 7.5. gData from34. Data obtained in 100 mM potassium phosphate, pH 7.5. 
hFADS from Escherichia coli. Data from43. Data obtained in 50 mM potassium phosphate, pH 7.5.
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column a freshly purified SpnFADS fraction considered as monomeric. This protein eluted as a main broad peak 
at ~14.5 mL (∼96% of the protein) but also produced a shoulder at ~13 mL (Fig. 3A). The peak at ~14.5 mL 
deconvolutes into three smaller peaks with apparent MWs of 61.2, 63.7 and 70 kDa. These values are slightly 
higher than the theoretic one for the monomer (34.8 kDa). The elongated structure of SpnFADS and the different 
conformations expected for its external loops could justify the reasonable assignment of those peaks to either 
different conformers of monomers or dimers. In contrast, the apparent MW of the shoulder at 13 mL is 127.4 kDa, 
Figure 2. Binding of ligands to SpnFADS. (A) Calorimetric titrations of SpnFADS with reduced FMN and 
FAD, performed at 20 °C in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2, 4 mM sodium dithionite, 10 mM glucose, 
0.5 U/mL glucose oxidase (degassed). (B) Calorimetric titrations of SpnFADS with ATP and of the preformed 
SpnFADS:ADP complex with RF or FMN, at 20 °C in 20 mM PIPES, pH 7.0, and at the indicated concentrations 
of MgCl2. In all titration figures upper panels show the thermograms for the interactions and the lower panels 
show the corresponding binding isotherms with integrated normalized heats. (C) Thermodynamic dissections 
of the interaction of SpnFADS with reduced FAD, reduced FMN and ATP, as well as of the preformed 
SpnFADS:ADP complex with RF and FMN. The binding Gibbs energy (ΔG), enthalpy (ΔH), and entropy 
(-TΔS) are represented in dark grey, light grey and white bars, respectively. MgCl2 concentrations in mM used 
in each experiment are indicated by numbers.
www.nature.com/scientificreports/
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suggesting this small protein fraction contains high MW oligomers. Pure preparations of SpnFADS also migrated 
in two bands on native gel electrophoresis, being one of them highly populated (band 1, Fig. 3B). According to the 
gel filtration data this band 1 can be putatively assigned to the monomer.
SDS-PAGE resolved the protein in a single band corresponding to the monomer MW, but pre-incubation of 
the protein with bis(sulfosuccinimidyl) suberate (BS3) crosslinker stabilized an additional band with an apparent 
MW of 78.6 kDa that can be assigned to a dimer (Fig. 3C). Altogether these data suggest that purified SpnFADS 
can be found in a monomer-dimer equilibrium that is mainly shifted towards the monomeric form, with traces 
of higher MW assemblies.
We used atomic force microscopy (AFM) to shed light on the SpnFADS assembly in solution, as well as on 
the possible effect of ligands in the monomer-oligomer equilibrium (Fig. 4A–F). AFM topography images of free 
SpnFADS indicate a compact monomer (height ~7 ± 1 nm) (Fig. 4A). Incubation of the enzyme with different 
combinations of substrates and/or its reaction products produced some dimers and trimers, while ADP also 
promoted the formation of tetramers (Fig. 4 and Table 3). Two types of images were found for dimers. In one of 
them the two protomers dispose parallel in the same plane with the tallest module of one interacting protomer 
with the smallest of the other, leaving the rest of these molecules free of contact (Fig. 4B). In the other dimer, the 
Receptor Ligand MgCl2 (mM) Kd (μM) ΔG (kcal/mol) ΔH (kcal/mol) −TΔS (kcal/mol)
N (binding 
stoichiometry)
SpnFADS
ATP 0 1.7 −7.9 −19.1 11.2 ∼1
0.8 9.4 −6.9 −27.8 23.0 ∼1
10 9.2b −6.9b −3.0b −3.9b ∼2
ADP 0 4.1 −7.3 −12.9 5.5 ∼1
10 30.0 −6.2 −19.4 13.3 ∼1
RF, 
FMN, 
FAD
0 n.d. n.d. n.d. n.d. n.d.
10
FMNa 0.8 0.8 −8.3 −5.8 −2.5 ∼1
FADa 0.8 12.5 −6.7 −5.6 −1.1 ∼1
SpnFADS:ADP
RF 0 0.3 −9.0 −17.2 8.2 ∼1
10 51.3b −5.9b −51.6b 45.7b ∼2
FMN 0 1.5 −7.9 −12.8 4.9  < 1
10 5.9 −7.1 −28.6 21.5  < 1
SpnFAD:PPi FAD 0 n.d. n.d. n.d. n.d. n.d.
Table 2. Thermodynamic parameters for the interaction of SpnFADS with the substrates and products of its 
activities obtained by ITC. Data obtained at 20 °C in 20 mM PIPES, pH 7.0. Estimated errors in Kd are ± 20% 
and ± 0.3 kcal/mol in ΔH and –TΔS. n.d. No enthalpic change was detected along the titration. aMeasurements 
performed in the presence of 4 mM sodium dithionite, 10 mM glucose and 0.5 U/ml glucose oxidase. bData 
corresponding to average values of two similar and independent binding sites (Kd,av, ΔGav, ΔHav, −TΔSav).
Figure 3. Hydrodynamic properties of SpnFADS. (A) Gel-filtration chromatogram of pure SpnFADS (20 µM) 
using a precalibrated SuperdexTM 200 10/300 GL column (GE Healthcare) equilibrated with 50 mM Tris/
HCl, pH 8.0, 150 mM NaCl, and calibrated with the Gel Filtration Calibration Kit LMW (GE Healthcare). The 
inset shows the percentage of the fractions obtained from the chromatogram. (B) 12% Native PAGE of pure 
SpnFADS. The two major bands are denoted by number; 1 for predicted oligomers and 2, the most populated, 
for the putative monomer. (C) 15% SDS-PAGE of SpnFADS without crosslinker and after incubation with the 
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most frequent, both protomers are on the same plane establishing different angles and slightly overlapping one 
module of the first onto one of the modules of the other (Fig. 4C). Both dimers appear as intermediate steps in 
the formation of the two trimeric species visualized in the images (Fig. 4D and E), which situate an additional 
monomer over one of the monomers of the dimeric structures. Considering the disposition adopted by the three 
molecules present in the asymmetric unit of the SpnFADS crystal (Fig. 4G), where each protomer is situated in a 
different plane, the trimers in solution differ from such crystallographic association. Finally, tetramers form two 
layers of two overlapped monomers (Fig. 4F). Incubation of SpnFADS with ATP and FMN, ADP and FMN, or 
FAD and PPi, produced the higher ratios of trimeric species, ~41%, while the RFK activity reactants, ATP and RF, 
generated 30% of dimeric molecules and only 16% of trimers. ATP by itself produced 37% of trimers, meanwhile 
Figure 4. Image analysis of SpnFADS assemblies. Topography AFM images of a scanned area of 167 × 167 nm 
and Z-height profiles associated to the lines on the features of SpnFADS samples. (A) Monomer. (B) Dimer on 
the same plane. (C) Dimer with an overlapping on a monomer on the other. (D) Trimer from (B) showing an 
overlapped dimer interacting with a monomer. (E) Trimer from (C) showing overlapping of the dimer on a 
monomer. The different sizes of the original scanned images slightly change the roughness of the surface and 
the lateral resolution. This affects the size of the features in X-Y but not the Z-height measured in the profiles. 
(F) Tetramer. (G) Blender simulation of different assemblies according to the presence or absence of ligands and 
assembly of the three SpnFADS molecules in the crystal asymmetric unit (PDB ID: 3OP1).
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ADP makes 20% of trimers and 47% of tetramers (Table 3). Incubation with the reactants of the FMNAT and 
FADpp activities resembles the same oligomeric yields. Since neither oxidized FMN nor FAD are able to bind to 
SpnFADS in the absence of adenine nucleotides, these data suggest that binding of adenine nucleotides (ATP and 
ADP) promotes the observed quaternary assemblies.
Discussion
Sequence alignments, structural comparisons10, 13, 36 and ligand binding models (Supplementary Fig. S1, and 
Fig. 5A) suggested that SpnFADS contains all the features of prokaryotic FADSs contributing to substrates stabili-
zation and catalysis. Accordingly, we show here that the enzyme catalyzes the RFK, FMNAT and FADpp activities, 
but we also highlight different requirements for catalysis and binding of ligands relative to other family members. 
Interestingly while transformation of RF into FMN by SpnFADS occurs similarly under both aerobic and reduc-
ing conditions, the FMNAT and FADpp activities require reduced flavins (Fig. 1). Reducing conditions hardly 
influence any of the CaFADS activities5, 33 (Table 1), but some bifunctional FADSs as well as the monofunctional 
HsRFK (Homo sapiens RFK) are more active in the presence of high concentrations of reducing agents34, 35, 42, 43. 
Moreover, studies of enriched samples of the FADS from Bacillus subtilis (BsFADS) early suggested specificity for 
reduced flavins in all its activities4.
Despite the differences in the redox requirements for the RFK and FMNAT activities between SpnFADS and 
CaFADS, both enzymes showed the highest efficiency for the synthesis of FMN and FAD compared to the other 
family enzymes reported up to now (Table 1)5, 33, 35, 42, with the lack of inhibition by the RF substrate for the 
RFK activity in SpnFADS (Fig. 1C) as a notable difference between them. Our ITC data indicate that SpnFADS 
does not bind any of its oxidized flavinic substrates when adenine nucleotides are not present (Supplementary 
Fig. S4), contrary to CaFADS5, 33. Reducing conditions are not a requirement for the binding of adenine nucle-
otides (ATP and ADP) (Fig. 2), and the presence of the adenine nucleotide also induces binding of oxidized RF 
or FMN. Nevertheless, such ternary interactions in SpnFADS are slightly weaker than in CaFADS1. Moreover, 
in the presence of the adenine nucleotide, oxidized FMN only binds at one site, which according to the enzyme 
capability to transform oxidized RF into FMN must be the RFK site (Table 2). The fact that oxidized RF does not 
bind to free SpnFADS, the lack of inhibition by RF, and the enzyme being catalytically efficient at low RF concen-
trations, suggest a dissimilar RFK mechanism between this enzyme and CaFADS44. Furthermore, the enzymatic 
and ligand binding characterizations of SpnFADS altogether confirm that competent flavin binding for catalysis 
at the FMNAT site requires the flavin ring in its reduced state. In addition, SpnFADS needs higher concentrations 
of substrates than CaFADS to achieve maximal efficiency.
The need for reduced flavinic substrates in BsFADS was interpreted as the geometry of the active site only 
allowing the incorporation of isoalloxazine rings in the reduced bended conformations, contrary to the highly 
stable planar organization adopted by their oxidized states4, 17, 45, 46. Despite the high conservation grade in over-
all folding (Supplementary Fig. S1) and key active sites residues, CaFADS and SpnFADS are dissimilar in some 
regions involved in ligand binding (Fig. 5B and Supplementary Fig. S1). In the FMNAT module of SpnFADS 
helixes α310n and α5n break loops L4n and L6n, respectively. These regions form the external part of the cavity 
where substrates for the FMNAT and FADpp activities bind. The sites for the ribityl and isoalloxazine moieties are 
formed in both enzymes by hydrophobic and aromatic side-chains (Fig. 6A), whose differential spatial position 
might determine cavity volumes and, therefore, modes for flavin binding. The cavity appears slightly broader 
and deeper in SpnFADS than in CaFADS, although in SpnFADS the isoalloxazine binding site surface is rougher 
Ligands Units
ASSOCIATION STATE
Monomers (%) Dimers (%) Trimers (%)
Tetramers 
(%)
—
Features 97 3 — —
Molecules 94 6 — —
ADP
Features 60 7 13 20
Molecules 31 7 20 47
ATP
Features 70 12 18 —
Molecules 47 16 37 —
ATP, RF
Features 73 20 7 —
Molecules 54 30 16 —
ATP, FMN
Features 73 7 20 —
Molecules 50 9 41 —
ADP, FMN
Features 63 15 22 —
Molecules 40 19 41 —
FAD, PPi
Features 73 7 20 —
Molecules 50 9 41 —
Table 3. Percentages of SpnFADS assemblies imaged by AFM. Samples of 0.5 μM SpnFADS were analyzed in 
20 mM PIPES, pH 6.0, 2 mM DTT and 0.8 mM MgCl2 at room temperature. When indicated, ADP, ATP or PPi 
were added at 250 μM, while oxidized FAD, FMN and RF were used at 50 μM. Features correspond to image 
units, while molecules refer to the amount of individual protein monomers in the corresponding image units. 
Error associated to percentage determination was ± 10%.
www.nature.com/scientificreports/
9SCIeNtIFIC RepoRTS | 7: 7609  | DOI:10.1038/s41598-017-07716-5
and shows a more negative surface electrostatic potential (Fig. 6B). The side chains of two Met residues, M54 and 
M118, form also part of the flavin ring cavity in SpnFADS, with M54 particularly prone to contact with the inner 
isoalloxazine ring (Fig. 6C). These Met residues are not conserved in most family members, which have instead 
hydrophobic residues13. Moreover, M54 forms part of a conserved sequence motif that is included only in few 
members such as BsFADS.
Structural differences are also observed when comparing the SpnFADS RFK module with the structures available 
for the CaFADS RFK module free and in complex with ligands (Figs 5 and 7)36: i) D214 at loop L2c of SpnFADS salt 
bridges R190 at β1c; ii) loop L3c is 12 residues shorter; iii) the C-terminal is considerably shorter; and iv) an extra α 
helix, α1c, breaks loop L1c-Flap I. In addition, conformations of the conserved PTAN motif and of L1c-FlapI in free 
SpnFADS resemble those elements in the CaFADS:FMN:ADP-Mg2+ complex. Such organization leaves the adenine 
nucleotide binding site open and the PTAN motif ready to stabilize the ligand (Fig. 7), contrary to free CaFADS36. 
Thus, the weaker affinity of SpnFADS for the RFK activity products might be related with the lack of large confor-
mational changes at the active site for substrates association and products dissociation during catalysis. These traits 
surely also contribute to the lack of inhibition by the RF substrate in SpnFADS.
Finally, substrates and products of SpnFADS induce formation of dimers, tetramers and particularly trimers 
with head-to-tail contacts between the RFK module and the FMNAT module of different protomers (Table 3, 
Fig. 4). None of these organizations resembles the CaFADS dimer-of-trimers and in general the SpnFADS 
monomer appears to be majority47. The PDBePISA server predicts dimeric assemblies with head-to-tail fits 
(Supplementary Fig. S5 and Table S1), but it does not predict any higher oligomer as stable in solution. Differences 
in oligomerization profiles might relate with differences in protein oligomerization regions. In fact, a long L3c, 
only expected for Corynebacterium and Mycobacterium species, is predicted as a determinant to stabilize the 
dimer-of-trimers47. The shorter loop in SpnFADS agrees with this hypothesis, being less prone to oligomeriza-
tion and establishing different contacts among protomers, which might also contribute to the dissimilar bind-
ing, kinetic and inhibition properties among species. The dimer-of-trimers in CaFADS envisaged a controlled 
interplay between the regions involved in the formation of the RFK and/or FMNAT catalytic sites of different 
protomers as well as in flavin delivery to client apoflavoproteins48, 49. However, such mechanism might not be 
required for SpnFADS, since in this enzyme the main regulation mechanism for the FAD synthesis seems to be 
the reducing environment.
In conclusion, SpnFADS is a prokaryotic bifunctional FADS that folds in two modules, the C-terminal one 
being responsible for the RFK activity and the N-terminal one accounting for the FMNAT and FADpp activities. 
Three main characteristics distinguish SpnFADS from the previously well characterized CaFADS: i) its FMNAT 
module only binds and transforms flavins in their reduced state, ii) its RFK activity does not exhibit inhibition 
by excess of RF substrate and iii) only dimers and trimers appear to be formed during catalysis. Considering the 
low number of members of the prokaryotic FADS family hitherto characterized, a large dissimilarity of optimal 
Figure 5. The structure of SpnFADS. (A) Model (based on PDB ID: 3OP1) for the interaction of SpnFADS with 
its ligands. The FMNAT module is shown in green and the RFK in yellow. Flavin and adenine nucleotide ligands 
are in CPK colored sticks with carbons in white. Mg2+ ions are shown as grey balls. Modelling performed using 
PyMol. (B) Superposition of the structures of SpnFADS (green, PDB ID: 3OP1) and CaFADS (orange, PDB ID: 
2X0K). Dissimilar regions are highlighted in blue and pink, respectively, including the numbers of implicated 
residues in SpnFADS.
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Figure 6. Comparative analysis of the SpnFADS and CaFADS active sites in the FMNAT module. (A) Site for 
ligands binding in SpnFADS (green) and CaFADS (orange). Hydrophobic and aromatic side chains are shown 
in sticks. (B) Surface electrostatic potential for the isoalloxazine binding cavity in SpnFADS (left panel) and 
CaFADS (right panel). Arrows point to differences in sign of surface electrostatic potential at the SpnFADS and 
CaFADS isoalloxazine sites. (C) Relative disposition of M54 and M118 regarding the isoalloxazine moiety of the 
flavin substrate. In all panels, FMN and AMP have been modelled on the crystals structures of SpnFADS (PDB 
ID: 3OP1) and CaFADS (PDB ID: 2X0K) and represented in CPK sticks with carbons in grey10.
www.nature.com/scientificreports/
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conditions for catalysis is envisaged. FADSs have a major functional role providing flavin cofactors to the cellular 
flavoproteome while also promoting flavins and flavoproteins homeostasis in all living organisms. In this context 
substrate inhibition, the use of reduced substrates or the formation of oligomeric assemblies might reflect differ-
ent regulation mechanisms used by the enzyme to withstand relatively different environments. Such, differences 
among family members provide with a framework to the design of selective compounds targeting FADS for the 
treatment of diverse infectious diseases.
Methods
Cloning, Overexpression and Purification of SpnFADS. The DNA sequence encoding SpnFADS 
(accession number ADM84672, SPAP_1083), containing the NdeI and XhoI restriction sites and codons opti-
mized for its expression in E. coli, was synthetically produced by Gen-Script. This DNA sequence was cloned into 
a modified pET-15b vector (Novagen) that contains an N-terminal His6-Tag sequence followed by a PreScission 
Protease site upstream of the NdeI and XhoI cloning sites. The final construct was fully sequenced at Sistemas 
Genómicos (www.sistemasgenomicos.com) and transformed into the E. coli strain Bl21 StarTM (DE3) (Invitrogen). 
Transformed cells were grown at 37 °C in 2xTY medium (1.6% (w/v) tryptone, 1% (w/v) yeast extract, and 0.5% 
(w/v) NaCl) with 100 μg/mL of ampicillin until cells reached an OD600 of 0.6. Then the culture was cooled down 
to 18 °C and protein expression was induced by addition of 1 mM isopropyl β-D-1-thiogalactopyranoside. After 
20 h of incubation at 18 °C, cells were harvested by centrifugation and suspended in 20 mM sodium phosphate, 
pH 7.4, 500 mM NaCl and 10 mM imidazole, containing lysozyme (1 mg/mL), DNase (0.1 mg/mL) and protease 
inhibitors (0.2 mM Phenylmethanesulfonyl fluoride (PMSF) and 10 mM benzamidine). After 30 min of incuba-
tion at 37 °C, cells were broken by sonication and centrifuged. The supernatant containing the soluble protein was 
loaded into a His-Trap affinity column (HisTrap HP, GE Healthcare) and the washing flow was discarded. Protein 
was eluted applying a gradient from 10 to 500 mM imidazole in 20 mM sodium phosphate, pH 7.4, 500 mM 
Figure 7. Comparative analysis of the RFK sites of SpnFADS, CaFADS and the CaFADS:FMN:ADP-Mg2+ 
ternary complex. (A) Cartoon representation of the RFK domains of SpnFADS (green, PDB ID: 3OP1), CaFADS 
(orange, PDB ID: 2X0K) and ternary complex of the RFK module of CaFADS (blue, PDB ID: 5A8A). L1c-FlapI 
is highlighted in red, pink and yellow, respectively. Residues of the PTAN motif are in CPK sticks. The FMN 
and ADP ligands bound to the CaFADS RFK module are in white CPK and Mg2+ is included as a green sphere. 
(B) Detail of the PTAN motif in SpnFADS and superposition of the PTAN motives of the three structures. (C) 
Superposition of the RFK domain of SpnFADS (green) and CaFADS (orange). The salt bridge between D214 at 
L2c and R190 at β1c of SpnFADS is in black dashes. Equivalent residues in CaFADS, D215 and T190, are drawn 
in sticks. Loops L3c are colored in blue (SpnFADS) and pink (CaFADS).
www.nature.com/scientificreports/
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NaCl. Buffer was exchanged to 25 mM Tris/HCl, pH 7.4, 150 mM NaCl, using a HiPrep Desalting Column (GE 
Healthcare). The His6-Tag was removed by 48 h-incubation with PreScission protease (GE Healthcare) at 4 °C, in 
ratio 1:5 (w/w), and then the protein was loaded into the HisTrap HP and GSTrap 4B connected columns (GE 
Healthcare) to eliminate both the remained His6-Tagged SpnFADS and the PreScission protease (a GST fused 
product). The unbound fraction was recovered and further purified by size exclusion chromatography using a 
SuperdexTM 200 10/300 GL column (GE Healthcare) previously equilibrated with 20 mM PIPES, pH 7.0, 150 mM 
NaCl. Protein purity was assessed by 15% SDS-PAGE and NaCl was removed by dialysis in 25 mM Tris/HCl, pH 
7.5 or 20 mM PIPES, pH 7.0 depending on later use. Pure protein solution was stored at −80 °C.
Spectroscopic Analysis. UV-visible spectra were recorded in a Cary 100 spectrophotometer (Varian) and 
SpnFADS was quantified using the theoretical ε279nm = 28.88 mM−1·cm−1 and a molecular weight of 34,521 Da 
(ProtParam). Circular dichroism (CD) spectra were recorded with a Chirascan spectropolarimeter (Applied 
Photophysics Ltd.) at 25 °C. Samples containing ∼5 and ∼20 µM SpnFADS in 25 mM Tris/HCl, pH 7.5 were used 
in the far-UV (cuvette path length, 0.1 cm) and near-UV CD (cuvette path length, 0.4 cm), respectively.
Qualitative and quantitative analysis of the activities of SpnFADS. RFK, FMNAT and FADpp 
activities of SpnFADS were qualitatively assayed by separating the different flavins present in the reaction mix-
tures using thin layer chromatography on Silica Gel SIL-G-25 plates as previously described13. Reaction mixtures 
containing 50 μM flavin (either RF, FMN or FAD), 0.2 mM ATP or PPi, 0.8 or 10 mM MgCl2, and 0.5 μM SpnFADS 
in 150 μL of 50 mM Tris/HCl, pH 8.0, were incubated in the presence of different sodium dithionite concentra-
tions (0–16 mM) at 25 °C during 30 min. The reaction was stopped by boiling the samples at 100 °C for 5 min. 
Flavin mixtures containing 50 µM of each flavin, RF, FMN and FAD, were included as standards. Flavin TLC spots 
were examined by monitoring their fluorescence under UV light.
RFK and FMNAT activities of SpnFADS were quantitatively measured at 25 °C in 20 mM PIPES, pH 7.0, 
0–10 mM MgCl2 as previously described5, 33, and when indicated 0–10 mM sodium dithionite was also added. 
Reaction mixtures (total volume 500 μL) containing 0.5–15 µM RF or 1–55 µM FMN, and 10–400 µM ATP were 
pre-incubated at 25 °C until reaction was initiated by addition of ∼25 nM enzyme. In all cases, reaction was 
stopped after 1 min of incubation through protein denaturation by boiling the sample for 5 min. Precipitated 
protein was removed from the solution by centrifugation at 18,000 x g during 10 min. The flavin composition 
of supernatants was analyzed using an Alliance HPLC system (Waters) equipped with a 2707 autosampler and 
an HSST3 column (4.6 × 150 mm, 3.5 µm, Waters) preceded by a precolumn (4.6 × 20 mm, 3.5 µm, Waters) 
as previously described5, 33. The produced amounts of FMN or FAD were quantified using their correspond-
ing standard curves acquired under the same conditions. The kinetic data obtained for one substrate at saturat-
ing concentrations of the second substrate (as nmol of flavin transformed per min) were interpreted using the 
Michaelis-Menten kinetic model, obtaining kcat and Km values with errors of ±10%. Controls for transformations 
of flavins in the absence of the enzyme under all reaction conditions showed only negligible processes.
Additional experiments were performed to elucidate whether reduced flavins are required for the FMNAT 
activity, or if the reducing environment is a requirement for the enzyme. Reaction mixtures containing 500 μM 
ATP, 15 μM FMN, 2 μM 5-deazaRF (5-dRF) and 0.8 mM MgCl2 in a final volume of 1 mL were deoxygenated 
during 1 h through Argon bubbling in the dark (to avoid FMN degradation). Once oxygen was displaced from 
the samples, previously deoxygenated SpnFADS was added at a final concentration of 100 nM. Then samples were 
illuminated during 15 s to photo-reduce FMN (the triplet state of 5-dRF, obtained by light-excitation, quickly 
evolves to a radical state that returns to the fundamental state by donating an electron to FMN). After 3 min of 
additional incubation samples were boiled for 5 min (to stop the reaction) and then centrifuged. Flavins present 
in the supernatant were identified by HPLC as we indicated above.
High-Sensitivity Isothermal Titration Calorimetry (ITC). ITC measurements were performed using 
an AutoITC200 calorimeter (MicroCal-Malvern) thermostated at 20 °C following the procedures previously 
reported5, 33. Typically, 300 μM nucleotide (ATP/ADP) or 150–200 μM flavin (RF/FMN/FAD) solutions were 
used to titrate ~20 μM SpnFADS solutions. When appropriate, ternary titrations were performed by adding flavin 
solutions to a mixture of the protein pre-incubated with 400 μM ADP. Ligands and SpnFADS were dissolved in 
20 mM PIPES pH 7.0, with 0, 0.8 or 10 mM MgCl2, and degassed prior to titration. Up to 19 injections of 2 µL were 
programmed with enough time spacing for the signal to recover the baseline. Similar protein concentrations in 
the calorimetric cell were employed in all experiments to guarantee that the oligomerization state of the protein 
is the same at any time. The association constant (Ka), the enthalpy change (ΔH) and the stoichiometry (N) were 
estimated through non-linear regression of the experimental data using a model for one or two independent 
binding sites; the regression was implemented in Origin 7.0 (OriginLab). The dissociation constant (Kd), the 
free energy change (ΔG), and the entropy change (ΔS) were obtained from basic thermodynamic relationships. 
Errors considered in the measured parameters ( ± 20% in Kd and ± 0.3 kcal/mol in ΔH and –TΔS) were taken 
larger than the standard deviation between replicates and the numerical error after the fitting analysis.
Titrations performed to elucidate whether SpnFADS was able to bind reduced FMN and FAD were performed 
using a high precision VP-ITC system (MicroCal LLC), and experimental sets were similar to those for the exper-
iments in the AutoITC200 calorimeter. Thus, 25 μM SpnFADS were titrated at 20 °C with FMN ≈ 200 μM or 
FAD ≈ 300 μM. Both the protein and the ligands were dissolved in 20 mM PIPES, pH 7.0, 0.8 mM MgCl2, 4 mM 
sodium dithionite, 10 mM glucose, 0.5 U/mL glucose oxidase, and degassed. Each titration was initiated by a 
4 μL injection followed by 25–28 stepwise injections of 10 μL. Glucose and glucose oxidase were added to avoid 
oxidation of sodium dithionite by molecular oxygen in order to avoid unspecific oxidation heat that could mask 
the one corresponding to the flavin:protein interaction.
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Evaluation of the hydrodynamic and quaternary organization properties. Stabilization of the 
quaternary organizations of SpnFADS was initially evaluated by gel filtration onto a SuperdexTM 200 10/300 GL 
column (GE Healthcare), equilibrated with 50 mM Tris/HCl, pH 8.0, 150 mM NaCl, and calibrated with the Gel 
Filtration Calibration Kit LMW (GE Healthcare)47. Oligomer formation was also analyzed by incubation of a pure 
fraction of SpnFADS in 50 mM KHPO4, pH 8.0 with BS3 crosslinker (Thermo Scientific) for 2 h at 4 °C. The cross 
reaction was stopped adding the quenching solution (Tris/HCl 500 mM (10x), pH 8.0) up to 50 mM and the dif-
ferent oligomeric states of the protein were visualized on a 15% SDS-PAGE gel.
For single molecule visualization of SpnFADS preparations, atomic force microscopy imaging was performed 
using a Multimode 8 AFM system (Bruker). Images were taken using the Tapping Mode with calibrated soft 
V-shaped silicon nitride cantilevers carrying pyramidal 2 nm ultrasharp tips characterized by spring constants 
ranged from 0.01 to 0.03 N/m and nominal resonance frequencies of 7 to 15 kHz (Bruker Probes). For samples 
containing ligands, the mixtures were pre-incubated at 4 °C for 10 min under mild stirring to favor complex 
formation prior to immobilization47. ADP, ATP and PPi were added at 250 µM, while FAD, FMN and RF were 
used at 50 µM. SpnFADS solutions (∼0.5 μM) were immobilized on small fresh exfoliated muscovite mica pieces 
(Electron Microscopy Sciences) for 10 min at room temperature. The sample and holder were introduced in a liquid 
cell previously cleaned with 20% isopropanol and Millipore ultrapure water. AFM measurements were conducted 
in 20 mM PIPES, pH 6.0, freshly prepared 2 mM dithiothreitol (DTT, Sigma-Aldrich) and 0.8 mM MgCl2 at room 
temperature. Raw images were processed using the WSxM freeware50. Percentages of different features were cal-
culated taking several sample areas with several scan sizes, zooming with the WSxM software functions without 
losing relevant information and discarding artifacts51. A considerable amount of features were collected for the 
statistical population study. Total protein percentages were also calculated considering the number of molecules 
involved in each type of association. Errors were calculated from the dispersion of results in the analysis of differ-
ent AFM images corresponding to different areas of the sample.
Structural prediction of enzyme-ligand interactions. Models for ligand binding at the RFK and 
FMNAT sites of SpnFADS were produced comparing its structure (chain B of the crystal structure PDB ID: 3OP1) 
with the previously reported CaFADS crystal structures (for the RFK module) or models (FMNAT module) in 
complex with their oxidized substrates10, 36. The PyMol 0.9952 software was used for complex modelling, structural 
analysis and figures production.
Data availability statement. All data generated or analyzed during this study are included in this pub-
lished article (and in its Supplementary Information files).
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